Skip to main content
Nykode Therapeutics AS (VACBF)
OTCMKTS · Delayed Price · Currency is USD
0.2749
0.00 (0.00%)
At close: Apr 23, 2025

Nykode Therapeutics AS Revenue

In the year 2024, Nykode Therapeutics AS had annual revenue of $9.16M, down -31.26%. Nykode Therapeutics AS had revenue of $6.89M in the quarter ending December 31, 2024, with 227.46% growth.

Revenue
9.16M
Revenue Growth
-31.26%
P/S Ratio
9.47
Revenue / Employee
67.34K
Employees
139
Market Cap
86.71M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.16M-4.17M-31.26%
Dec 31, 202313.32M4.29M47.56%
Dec 31, 20229.03M-26.74M-74.76%
Dec 31, 202135.77M-179.93M-83.42%
Dec 31, 2020215.70M214.28M15,175.85%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Nykode Therapeutics AS News

More News